Cargando…
Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus
INTRODUCTION: PET imaging of amyloid-β (Aβ) in vivo holds promise for aiding in earlier diagnosis and intervention in Alzheimer’s disease (AD) and mild cognitive impairment. AD-like Aβ pathology is a common comorbidity in patients with idiopathic normal pressure hydrocephalus (iNPH). Fifty patients...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003513/ https://www.ncbi.nlm.nih.gov/pubmed/24755237 http://dx.doi.org/10.1186/2051-5960-2-46 |
_version_ | 1782313856008192000 |
---|---|
author | Leinonen, Ville Rinne, Juha O Wong, Dean F Wolk, David A Trojanowski, John Q Sherwin, Paul F Smith, Adrian Heurling, Kerstin Su, Mandy Grachev, Igor D |
author_facet | Leinonen, Ville Rinne, Juha O Wong, Dean F Wolk, David A Trojanowski, John Q Sherwin, Paul F Smith, Adrian Heurling, Kerstin Su, Mandy Grachev, Igor D |
author_sort | Leinonen, Ville |
collection | PubMed |
description | INTRODUCTION: PET imaging of amyloid-β (Aβ) in vivo holds promise for aiding in earlier diagnosis and intervention in Alzheimer’s disease (AD) and mild cognitive impairment. AD-like Aβ pathology is a common comorbidity in patients with idiopathic normal pressure hydrocephalus (iNPH). Fifty patients with iNPH needing ventriculo-peritoneal shunting or intracranial pressure monitoring underwent [(18)F]flutemetamol PET before (N = 28) or after (N = 22) surgery. Cortical uptake of [(18)F]flutemetamol was assessed visually by blinded reviewers, and also quantitatively via standard uptake value ratio (SUVR) in specific neocortical regions in relation to either cerebellum or pons reference region: the cerebral cortex of (prospective studies) or surrounding (retrospective studies) the biopsy site, the contralateral homolog, and a calculated composite brain measure. Aβ pathology in the biopsy specimen (standard of truth [SoT]) was measured using Bielschowsky silver and thioflavin S plaque scores, percentage area of grey matter positive for monoclonal antibody to Aβ (4G8), and overall pathology impression. We set out to find (1) which pair(s) of PET SUVR and pathology SoT endpoints matched best, (2) whether quantitative measures of [(18)F]flutemetamol PET were better for predicting the pathology outcome than blinded image examination (BIE), and (3) whether there was a better match between PET image findings in retrospective vs. prospective studies. RESULTS: Of the 24 possible endpoint/SoT combinations, the one with composite-cerebellum SUVR and SoT based on overall pathology had the highest Youden index (1.000), receiver operating characteristic area under the curve (1.000), sensitivity (1.000), specificity (1.000), and sum of sensitivity and specificity for the pooled data as well as for the retrospective and prospective studies separately (2.00, for all 3). The BIE sum of sensitivity and specificity, comparable to that for quantitation, was highest using Bielschowsky silver as SoT for all SUVRs (ipsilateral, contralateral, and composite, for both reference regions). The composite SUVR had a 100% positive predictive value (both reference regions) for the overall pathology diagnosis. All SUVRs had a 100% negative predictive value for the Bielschowsky silver result. CONCLUSION: Bielschowsky silver stain and overall pathology judgment showed the strongest associations with imaging results. |
format | Online Article Text |
id | pubmed-4003513 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40035132014-04-30 Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus Leinonen, Ville Rinne, Juha O Wong, Dean F Wolk, David A Trojanowski, John Q Sherwin, Paul F Smith, Adrian Heurling, Kerstin Su, Mandy Grachev, Igor D Acta Neuropathol Commun Research INTRODUCTION: PET imaging of amyloid-β (Aβ) in vivo holds promise for aiding in earlier diagnosis and intervention in Alzheimer’s disease (AD) and mild cognitive impairment. AD-like Aβ pathology is a common comorbidity in patients with idiopathic normal pressure hydrocephalus (iNPH). Fifty patients with iNPH needing ventriculo-peritoneal shunting or intracranial pressure monitoring underwent [(18)F]flutemetamol PET before (N = 28) or after (N = 22) surgery. Cortical uptake of [(18)F]flutemetamol was assessed visually by blinded reviewers, and also quantitatively via standard uptake value ratio (SUVR) in specific neocortical regions in relation to either cerebellum or pons reference region: the cerebral cortex of (prospective studies) or surrounding (retrospective studies) the biopsy site, the contralateral homolog, and a calculated composite brain measure. Aβ pathology in the biopsy specimen (standard of truth [SoT]) was measured using Bielschowsky silver and thioflavin S plaque scores, percentage area of grey matter positive for monoclonal antibody to Aβ (4G8), and overall pathology impression. We set out to find (1) which pair(s) of PET SUVR and pathology SoT endpoints matched best, (2) whether quantitative measures of [(18)F]flutemetamol PET were better for predicting the pathology outcome than blinded image examination (BIE), and (3) whether there was a better match between PET image findings in retrospective vs. prospective studies. RESULTS: Of the 24 possible endpoint/SoT combinations, the one with composite-cerebellum SUVR and SoT based on overall pathology had the highest Youden index (1.000), receiver operating characteristic area under the curve (1.000), sensitivity (1.000), specificity (1.000), and sum of sensitivity and specificity for the pooled data as well as for the retrospective and prospective studies separately (2.00, for all 3). The BIE sum of sensitivity and specificity, comparable to that for quantitation, was highest using Bielschowsky silver as SoT for all SUVRs (ipsilateral, contralateral, and composite, for both reference regions). The composite SUVR had a 100% positive predictive value (both reference regions) for the overall pathology diagnosis. All SUVRs had a 100% negative predictive value for the Bielschowsky silver result. CONCLUSION: Bielschowsky silver stain and overall pathology judgment showed the strongest associations with imaging results. BioMed Central 2014-04-22 /pmc/articles/PMC4003513/ /pubmed/24755237 http://dx.doi.org/10.1186/2051-5960-2-46 Text en Copyright © 2014 Leinonen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Leinonen, Ville Rinne, Juha O Wong, Dean F Wolk, David A Trojanowski, John Q Sherwin, Paul F Smith, Adrian Heurling, Kerstin Su, Mandy Grachev, Igor D Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus |
title | Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus |
title_full | Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus |
title_fullStr | Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus |
title_full_unstemmed | Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus |
title_short | Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus |
title_sort | diagnostic effectiveness of quantitative [(18)f]flutemetamol pet imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003513/ https://www.ncbi.nlm.nih.gov/pubmed/24755237 http://dx.doi.org/10.1186/2051-5960-2-46 |
work_keys_str_mv | AT leinonenville diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus AT rinnejuhao diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus AT wongdeanf diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus AT wolkdavida diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus AT trojanowskijohnq diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus AT sherwinpaulf diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus AT smithadrian diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus AT heurlingkerstin diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus AT sumandy diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus AT grachevigord diagnosticeffectivenessofquantitative18fflutemetamolpetimagingfordetectionoffibrillaramyloidbusingcorticalbiopsyhistopathologyasthestandardoftruthinsubjectswithidiopathicnormalpressurehydrocephalus |